The Changing Landscape of Treating CML

 

2022 West Oncology Conference
A

2022 Highlights and Advances in Myeloid Neoplasms

By 2022 West Oncology Conference FEATURING Abdulraheem Yacoub
By 2022 West Oncology Conference FEATURING Abdulraheem Yacoub
150 views
March 15, 2022
0 Comments
Login to view comments. Click here to Login
The Changing Landscape of Treating CML
06:33
ASCO 2022 Conference Coverage

ASCO 2022 Treatment-Free Remission in CML Patients Following the Dis…

Feat. F. Haddad
36
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Treatment-Free Remission in CML Patients…

Feat. F. Haddad
11:45
ASCO 2022 Conference Coverage

ASCO 2022 Efficacy & Safety Results From the Phase 3 ASCEMBL Stu…

Feat. J. Cortés
28:25
Michael Deininger

The Role of Genomic Analysis and Panel Mutation Screening in the Con…

21:53
2022 West Oncology Conference

2022 Highlights and Advances in Myeloid Neoplasms

Feat. A. Yacoub
05:46
Total Health

Review of the ASCEMBL Study: Asciminib vs. Bosutinib in CP-CML After…

Feat. T. Kadia
09:18
ESMO 2022 Conference Coverage

ESMO 2022 Congress Highlights: Hematological Malignancies

Feat. I. Glimelius
56
ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 Congress Highlights: Hematological Malig…

Feat. I. Glimelius
09:32
Susanne Saussele

Treatment-Free Remission in CML

08:50
Daniel J. DeAngelo

Asciminib in the Treatment of CML

15:48
SOHO 2022 Tenth Annual Meeting

SOHO 2022: State of the Art in CML

Feat. M. Deininger, G. Saglio
09:54
SOHO 2022 Tenth Annual Meeting

SOHO 2022 Next Questions: CML

Feat. T. Hughes
16:32
SOHO 4th Italian Conference

SOHO Italy 2022: How I Treat CML at MDACC in 2022

Feat. E. Jabbour
16:33
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Asciminib or Ponatinib for Multiresistant CML Patients?

Feat. J. Cortés